Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, 9th Floor, Mohammad Rasoul Allah Research Tower, Khalili St, PO Box: 7193635899, Shiraz, Iran.
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Eur J Med Res. 2023 Jan 3;28(1):4. doi: 10.1186/s40001-022-00908-4.
Corona Virus Disease 2019 (COVID-19) presentations range from those similar to the common flu to severe pneumonia resulting in hospitalization with significant morbidity and/or mortality. In this study, we made an attempt to develop a predictive scoring model to improve the early detection of high risk COVID-19 patients by analyzing the clinical features and laboratory data available on admission.
We retrospectively included 480 consecutive adult patients, aged 21-95, who were admitted to Faghihi Teaching Hospital. Clinical and laboratory features were collected from the medical records and analyzed using multiple logistic regression analysis. The final data analysis was utilized to develop a simple scoring model for the early prediction of mortality in COVID-19 patients. The score given to each associated factor was based on the coefficients of the regression analyses.
A novel mortality risk score (COVID-19 BURDEN) was derived, incorporating risk factors identified in this cohort. CRP (> 73.1 mg/L), O saturation variation (greater than 90%, 84-90%, and less than 84%), increased PT (> 16.2 s), diastolic blood pressure (≤ 75 mmHg), BUN (> 23 mg/dL), and raised LDH (> 731 U/L) were the features constituting the scoring system. The patients are triaged to the groups of low- (score < 4) and high-risk (score ≥ 4) groups. The area under the curve, sensitivity, and specificity for predicting mortality in patients with a score of ≥ 4 were 0.831, 78.12%, and 70.95%, respectively.
Using this scoring system in COVID-19 patients, the patients with a higher risk of mortality can be identified which will help to reduce hospital care costs and improve its quality and outcome.
2019 年冠状病毒病(COVID-19)的表现范围从类似于普通流感的症状到导致住院的严重肺炎不等,其发病率和/或死亡率较高。在这项研究中,我们试图通过分析入院时的临床特征和实验室数据,建立一个预测评分模型来提高对高危 COVID-19 患者的早期检测。
我们回顾性纳入了 480 名年龄在 21-95 岁之间的连续成年患者,他们均被收入法希希教学医院。从病历中收集临床和实验室特征,并使用多元逻辑回归分析进行分析。最终数据分析用于开发一种简单的评分模型,以早期预测 COVID-19 患者的死亡率。为每个相关因素分配的分数基于回归分析的系数。
从该队列中确定了风险因素,得出了一种新的死亡率风险评分(COVID-19 负担)。CRP(>73.1mg/L)、氧饱和度变化(大于 90%、84-90%和小于 84%)、PT 增加(>16.2s)、舒张压(≤75mmHg)、BUN(>23mg/dL)和升高的 LDH(>731U/L)是构成评分系统的特征。患者被分诊到低危(评分<4)和高危(评分≥4)组。评分≥4 患者预测死亡率的曲线下面积、敏感性和特异性分别为 0.831、78.12%和 70.95%。
在 COVID-19 患者中使用该评分系统,可以识别出死亡率较高的患者,这有助于降低医院治疗成本,提高治疗质量和预后。